The Central Government has told the Supreme Court that "the vaccination policy has been framed in a lawful, impartial and non-discriminatory manner. Made it clear that it was not possible to vaccinate nationwide in a single instalment. The country will provide free vaccinations to people of all ages. Outbreaks appear to be exacerbated during this time, and vaccine doses are limited. It is learned that the Supreme Court bench headed by Justice DY Chandrachud is taking up the case of availability of emergency goods and services during covid. The court directed the central government to reconsider the vaccine price and policy and file an affidavit on it. Solicitor General Tushar Mehta filed the affidavit at midnight on Sunday on behalf of the Center. State governments and vaccine makers have called on the Supreme Court not to interfere in the vaccination process in the wake of the outbreak. The executive system should have complete freedom, keeping in view the wider public interest. Experts suggest that even well-intentioned intervention by the judiciary without administrative experience can lead to unintended and undesirable consequences. That way, doctors, scientists, professionals, and the executive will not have the opportunity to find creative solutions, "the centre said in a 218-page affidavit.
The state governments have already made it clear that they will vaccinate the people for free
Therefore, commented that setting the price for the vaccines would not affect the beneficiaries of the users. The central medical health department is making every effort to increase production and imports and increase the availability of represent. The Trips Agreement, along with the Patents Act 1970, and the Doha Declaration are likely to be challenged if they are enforced. The Central Government is actively working with international organizations to find a solution at the diplomatic level. The Center has made it clear that it has not provided any grants for the research and development of the Covaxin and Covishield vaccines, but has provided some financial assistance to complete the clinical trials. In May, June and July, Bharat Biotech paid Rs 1,732.50 crore for 11 crore Kovshield doses to Serum Institute and Rs 7,875 crore for 5 crore covaxin doses.
According to doctor Antony ,medical advisor of American governament suggested that lockdown is a temporary solution to restrict corona and vaccination is a permanent solution to restrict corona. So for this there is a need of expanding vaccine production.
Hope you like♥️ this and write your views in comment section.
